Related Experiment Video
Updated: May 8, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Early Recognition of Infantile Systemic Hyalinosis in a Palestinian Infant: A Case Report
Lilyan Jarrar1, Sara Mutan2, Lana Malhis3
1Jenin Governmental Hospital Jenin Palestine.
Insights
Infantile systemic hyalinosis (ISH) presents with contractures, skin changes, and diarrhea in infants from consanguineous families. Early diagnosis and supportive care are crucial for managing this rare genetic disorder.
Area of Science:
- Pediatric Genetics
- Rare Diseases
- Dermatology
Background:
- Infantile systemic hyalinosis (ISH) is a rare, severe genetic disorder.
- It typically manifests in infancy with distinctive clinical features.
Purpose of the Study:
- To highlight key clinical indicators for suspecting ISH.
- To emphasize the importance of early recognition and intervention.
Main Methods:
- Clinical case review and analysis of presenting symptoms.
- Genetic counseling and diagnostic considerations.
Main Results:
- Contractures, skin changes, and diarrhea are significant indicators of ISH.
- Consanguinity in families increases suspicion.
Conclusions:
- Early identification of ISH enables prompt genetic testing and supportive management.
- While prognosis is poor, timely intervention can improve family outcomes and care.
Abstract:
Infantile systemic hyalinosis should be suspected in infants with contractures, skin changes, and diarrhea in consanguineous families. Early recognition allows timely genetic testing, supportive care, and counseling, improving family outcomes despite poor prognosis.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
06:15Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019